Sabo Tamar, Kronman Chanoch, Mazor Ohad
The Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona, 74100, Israel.
Methods Mol Biol. 2016;1403:683-94. doi: 10.1007/978-1-4939-3387-7_38.
Ricin is one of the most potent and lethal toxins known to which there is no available antidote. Currently, the most promising therapy is based on neutralizing antibodies elicited by active vaccination or given passively. Here, detailed protocols are provided for the production of two ricin holotoxin-based vaccines: monomerized subunit-based vaccine, and a formaldehyde-based ricin toxoid vaccine. Both vaccines were found to be stable with no toxic activity reversion even after long-term storage while eliciting high anti-ricin antibody titers possessing a potent neutralizing activity. The use of these vaccines is highly suitable for both the production of sera that can be used in passive protection experiments and immunization aimed to isolate potent anti-ricin monoclonal antibodies.
蓖麻毒素是已知最具毒性和致命性的毒素之一,目前尚无可用的解毒剂。目前,最有前景的治疗方法是基于主动接种疫苗或被动给予所引发的中和抗体。在此,提供了两种基于蓖麻毒素全毒素的疫苗生产的详细方案:基于单体化亚基的疫苗和基于甲醛的蓖麻毒素类毒素疫苗。发现这两种疫苗都很稳定,即使长期储存后也没有毒性活性逆转,同时能引发具有强大中和活性的高抗蓖麻毒素抗体滴度。这些疫苗非常适合用于生产可用于被动保护实验的血清以及旨在分离强大抗蓖麻毒素单克隆抗体的免疫接种。